Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Ottawa

$17,500.00

The Release of Cardiac Troponin T within Exosomes in the Clinical Context of Type 1 vs. Type 2 Myocardial Infarction

FY 2023-24

Summary
Heart disease is a leading cause of death worldwide, with Heart Attacks (HA) at the forefront. There are two primary classes of HA. Type 1 (T1) is caused by a blockage of one or more of the heart arteries. Type 2 (T2) arises due to an oxygen supply/demand imbalance in the absence of a blockage. During the presentation with a suspected HA, standard diagnostic tests are conducted, namely a troponin T test. Troponin T comes in 4 forms and is differentially expressed through age or disease. It is found within the muscle cells of the heart and is critical in its contraction/relaxation. During a HA, troponin is released, and its detection signals a HA has occurred. There are two mechanisms of troponin release, free form associated with T1 or exosome bound with T2. Distinguishing between T1/T2 clinically is a challenge as they present similarly and both generate positive troponin tests, however, the treatment is different. Non-invasive methods to differentiate these disease states must be developed. Using plasma samples of T1/T2 HA, we will explore the rise of exosomal troponin in T2 and contrast with the T1 release profile. We will determine which form of troponin T is free/exosome bound, as well as other exosomal contents. By labeling troponin in exosomes, followed by their uptake into heart cells with subsequent microscopic analysis to visualize the location, we will identify troponin's intracellular targets. We hypothesize an increase in exosomal troponin in T2 compared to T1 as well as a different form of troponin T isolated in the exosome vs. the free form. Exosomal troponin is hypothesized to localize at the endoplasmic reticulum of the heart cells. Examining the variance in release and form of troponin T could prove valuable in developing differential diagnostics.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
508863
Name
Basiren Leyton
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The Release of Cardiac Troponin T within Exosomes in the Clinical Context of Type 1 vs. Type 2 Myocardial Infarction
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Biomarker; Cardiac Remodelling; Cardiovascular Disease; Exosome; Extracellular Vesicles; Troponin T; Type 1 Myocardial Infarction; Type 2 Myocardial Infarction
Abstract
Heart disease is a leading cause of death worldwide, with Heart Attacks (HA) at the forefront. There are two primary classes of HA. Type 1 (T1) is caused by a blockage of one or more of the heart arteries. Type 2 (T2) arises due to an oxygen supply/demand imbalance in the absence of a blockage. During the presentation with a suspected HA, standard diagnostic tests are conducted, namely a troponin T test. Troponin T comes in 4 forms and is differentially expressed through age or disease. It is found within the muscle cells of the heart and is critical in its contraction/relaxation. During a HA, troponin is released, and its detection signals a HA has occurred. There are two mechanisms of troponin release, free form associated with T1 or exosome bound with T2. Distinguishing between T1/T2 clinically is a challenge as they present similarly and both generate positive troponin tests, however, the treatment is different. Non-invasive methods to differentiate these disease states must be developed. Using plasma samples of T1/T2 HA, we will explore the rise of exosomal troponin in T2 and contrast with the T1 release profile. We will determine which form of troponin T is free/exosome bound, as well as other exosomal contents. By labeling troponin in exosomes, followed by their uptake into heart cells with subsequent microscopic analysis to visualize the location, we will identify troponin's intracellular targets. We hypothesize an increase in exosomal troponin in T2 compared to T1 as well as a different form of troponin T isolated in the exosome vs. the free form. Exosomal troponin is hypothesized to localize at the endoplasmic reticulum of the heart cells. Examining the variance in release and form of troponin T could prove valuable in developing differential diagnostics.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Basiren, Leyton
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~